TickerFactsScreenerDevelopers

AYTU BIOPHARMA, INC (AYTU) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$133.6K2012: -$56.4K2014: -$6.35M2015: -$7.63M2016: -$21.70M2017: -$20.13M2018: -$19.70M2019: -$16.85M2020: -$21.13M2021: -$58.87M2022: -$109.91M2023: -$17.07M2024: -$1.59M2025: -$7.83M-$7.83M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$7.83M-392.0%
2024-$1.59M+90.7%
2023-$17.07M+84.5%
2022-$109.91M-86.7%
2021-$58.87M-178.6%
2020-$21.13M-25.4%
2019-$16.85M+14.5%
2018-$19.70M+2.1%
2017-$20.13M+7.3%
2016-$21.70M-184.4%
2015-$7.63M-20.3%
2014-$6.35M—
2012-$56.4K+57.8%
2011-$133.6K—